DrugPatentWatch Database Preview
BENLYSTA Drug Profile
Summary for Tradename: BENLYSTA
| Patents: | 40 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for BENLYSTA
| Mechanism of Action | B Lymphocyte Stimulator-directed Antibody Interactions |
| Physiological Effect | Decreased B Lymphocyte Activation |
US Patents for BENLYSTA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 002 | 2011-03-09 | Start Trial | LegoChem Biosciences, Inc. (Daejeon, KR) | 2034-05-28 | RX | search | |
| Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 002 | 2011-03-09 | Start Trial | 2038-10-17 | RX | search | ||
| Human Genome Sciences Inc. | BENLYSTA | belimumab | INJECTABLE; INJECTION | 125370 | 002 | 2011-03-09 | Start Trial | CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) | 2032-11-08 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for BENLYSTA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Colombia | 6630082 | Start Trial |
| European Patent Office | 3020419 | Start Trial |
| Spain | 2590778 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
